Inflammation biotech Apimeds Pharmaceuticals US ( APUS) is tentatively scheduled to raise $20 million at a $58 million market ...
Private equity firms once had a script, of sorts. Buy an asset, load it up with debt, fix it and then flip it. But in recent years, weak M&A markets and soldered IPO windows have plugged the exit — ...
The carmaker will use the proceeds from the share placement for research and development and overseas expansion.
Wall Street loves a perfectly choreographed IPO, with more shares offered and prices ... Instead, three of the US’s four largest initial public offerings this year have traded below their ...
Mixue’s float has been the largest so far in what’s shaping up to be Hong Kong’s biggest year for IPOs since 2021.
SHARES of China’s largest bubble tea and drinks chain, Mixue Group, jumped more than 47 per cent in their debut on the Hong ...
AMERICA 2030, a $50 million secondary growth fund investing in U.S. defense, energy, security, and AI with Target Maturity in ...
Malaysia-based Yakin Medic plans to raise RM100 million from an IPO on the Catalist board of the Singapore Exchange , reports ...